Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-087312
Filing Date
2024-08-08
Accepted
2024-08-08 16:36:22
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-08-08

Document Format Files

Seq Description Document Type Size
1 ARS tm2421072d3_ars.pdf ARS 6560748
  Complete submission text file 0001104659-24-087312.txt   9038959
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-12957 | Film No.: 241189081
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)